Matches in Wikidata for { <http://www.wikidata.org/entity/Q91748124> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q91748124 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91748124 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91748124 description "scientific article published on 08 April 2020" @default.
- Q91748124 description "wetenschappelijk artikel" @default.
- Q91748124 description "наукова стаття, опублікована 8 квітня 2020" @default.
- Q91748124 name "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 name "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 type Item @default.
- Q91748124 label "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 label "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 prefLabel "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 prefLabel "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 P1433 Q91748124-0C3349FD-73C2-430C-A410-F230853F0586 @default.
- Q91748124 P1476 Q91748124-7B834028-AD84-47DA-BC91-6A815517CD6B @default.
- Q91748124 P2093 Q91748124-0F93C7F8-B568-45C0-B5AB-EF84C2BC9C93 @default.
- Q91748124 P2093 Q91748124-312AFED5-1FE5-4D38-897C-9A1006AC9C8A @default.
- Q91748124 P2093 Q91748124-3609E8EE-C0FA-4CBC-99C4-1D1B8E703A19 @default.
- Q91748124 P2093 Q91748124-549B5017-1426-4D70-849A-30263B920F74 @default.
- Q91748124 P2093 Q91748124-59D4AA61-DF8E-4924-9146-335018D088BF @default.
- Q91748124 P2093 Q91748124-67489C74-2763-4A6A-A5E6-7F9EAFCB2147 @default.
- Q91748124 P2093 Q91748124-6761C17D-BD2E-4E4E-AB5C-6993BAE4B93A @default.
- Q91748124 P2093 Q91748124-87B68285-0B93-49E2-BB61-29B2A294D72D @default.
- Q91748124 P2093 Q91748124-8E91A94A-49C2-4B38-90ED-3AF24E5840D4 @default.
- Q91748124 P2093 Q91748124-9811EED3-D577-46B4-A196-8D8B8CE9B633 @default.
- Q91748124 P2093 Q91748124-98D2B7E5-499E-4086-B34D-8E780CBA8BD5 @default.
- Q91748124 P2093 Q91748124-9EBD9F62-1CFC-46F2-8F6F-4F57EF5CBA97 @default.
- Q91748124 P2093 Q91748124-A2F91D8F-6C50-43E5-AAC7-BE1A9F66C375 @default.
- Q91748124 P2093 Q91748124-B3580D67-75AB-4324-95A1-44021C1CFDC6 @default.
- Q91748124 P2093 Q91748124-BE205DB0-F40E-43B6-8F76-D9E94B02EE9E @default.
- Q91748124 P2093 Q91748124-C46DCE96-CC77-4EEA-87AA-FE9DBFE8E0C0 @default.
- Q91748124 P2093 Q91748124-D7183884-4C1F-4152-A9E7-C6E686782FFF @default.
- Q91748124 P2093 Q91748124-E788D577-95DB-4D22-81E1-D559B21545D9 @default.
- Q91748124 P31 Q91748124-A4F5D617-93C2-4066-BD2A-1B6F9C54ECE7 @default.
- Q91748124 P356 Q91748124-EE554D68-C64F-4A60-8786-B0A8FEED7C16 @default.
- Q91748124 P50 Q91748124-9B4E9219-CDD1-4C9C-AE99-E184F7428E66 @default.
- Q91748124 P50 Q91748124-BD49D852-D6CD-456C-9F50-CDA46B772E3D @default.
- Q91748124 P577 Q91748124-91D6B85A-CFAE-4DD8-89C2-2B475FF1C35A @default.
- Q91748124 P698 Q91748124-EBFEDCD5-BE8B-4D7D-ACD3-FDC363223A41 @default.
- Q91748124 P921 Q91748124-EC08B069-CE3D-4EB3-A90D-40E891EA2C0A @default.
- Q91748124 P356 S00380-020-01598-W @default.
- Q91748124 P698 32270356 @default.
- Q91748124 P1433 Q15766690 @default.
- Q91748124 P1476 "Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention" @default.
- Q91748124 P2093 "Chang Gyu Park" @default.
- Q91748124 P2093 "Cheol Ung Choi" @default.
- Q91748124 P2093 "Dong Joo Oh" @default.
- Q91748124 P2093 "Dong Oh Kang" @default.
- Q91748124 P2093 "Eung Ju Kim" @default.
- Q91748124 P2093 "Hong Seog Seo" @default.
- Q91748124 P2093 "Jae Kyeong Byun" @default.
- Q91748124 P2093 "Jah Yeon Choi" @default.
- Q91748124 P2093 "Jin Oh Na" @default.
- Q91748124 P2093 "Jin-Seok Kim" @default.
- Q91748124 P2093 "Jinah Cha" @default.
- Q91748124 P2093 "Myung Ho Jeong" @default.
- Q91748124 P2093 "Se Yeon Choi" @default.
- Q91748124 P2093 "Seung-Young Roh" @default.
- Q91748124 P2093 "Won Young Jang" @default.
- Q91748124 P2093 "Woohyeun Kim" @default.
- Q91748124 P2093 "Yoonjee Park" @default.
- Q91748124 P2093 "other Korea Acute Myocardial Infarction Registry (KAMIR) investigators" @default.
- Q91748124 P31 Q13442814 @default.
- Q91748124 P356 "10.1007/S00380-020-01598-W" @default.
- Q91748124 P50 Q41876089 @default.
- Q91748124 P50 Q88106070 @default.
- Q91748124 P577 "2020-04-08T00:00:00Z" @default.
- Q91748124 P698 "32270356" @default.
- Q91748124 P921 Q18558122 @default.